Cargando…
Belatacept inhibit human B cell germinal center development in immunodeficient mice
The humoral response mediated by alloantibodies directed against donor HLA molecules (DSAs) is one of the main causes of graft loss in kidney transplantation. Understanding the pathophysiology leading to humoral kidney rejection as the development of therapeutic tools is therefore a main objective i...
Autores principales: | Samson, Chloé, Thiolat, Allan, Moktefi, Anissa, Cohen, José L., Pilon, Caroline, Grimbert, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449885/ https://www.ncbi.nlm.nih.gov/pubmed/37620431 http://dx.doi.org/10.1038/s41598-023-40700-w |
Ejemplares similares
-
Belatacept-based immunosuppressive regimen in HIV-positive kidney transplant recipients
por: El Sakhawi, Karim, et al.
Publicado: (2020) -
Three-Year Outcomes in Kidney Transplant Recipients Switched From Calcineurin Inhibitor-Based Regimens to Belatacept as a Rescue Therapy
por: Morel, Antoine, et al.
Publicado: (2022) -
Hepatitis B Virus Reactivation in Kidney Transplant Recipients Treated With Belatacept
por: Schwarz, Chloë, et al.
Publicado: (2023) -
Phenotypic and Transcriptomic Lymphocytes Changes in Allograft Recipients After Intravenous Immunoglobulin Therapy in Kidney Transplant Recipients
por: Pilon, Caroline, et al.
Publicado: (2020) -
Rituximab and Fibrillary Glomerulonephritis: Interest of B Cell Reconstitution Monitoring
por: Leibler, Claire, et al.
Publicado: (2018)